Pharma Journalist -

Solid Biosciences Inc., a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), announced the closing of its acquisition of…
Read More...

AbCellera and Rallybio Corporation announced that they have entered into a strategic alliance to discover, develop, and commercialize novel antibody-based therapeutics for rare…
Read More...

GSK plc announced that the European Medicines Agency (EMA) validated the marketing authorisation application (MAA) for momelotinib, a potential new oral treatment for myelofibrosis.…
Read More...

Immunocore Holdings plc, a commercial-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a…
Read More...

Rocket Pharmaceuticals, Inc. announces that it has completed the previously announced acquisition of Renovacor, Inc., a biotechnology company focused on delivering innovative precision…
Read More...

Solid Biosciences Inc. a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), announced the results of the special meeting of the…
Read More...

PTC Therapeutics, Inc. announced that the Brazilian Health Regulatory Agency, ANVISA (Agência Nacional de Vigilância Sanitária), has approved Waylivra (volanesorsen) as the first…
Read More...

TherapeuticsMD, Inc. an innovative, leading women’s healthcare company, today announced that it has entered into definitive agreements to license its products to an affiliate of Mayne…
Read More...

Incyte and CMS Aesthetics, a dermatology medical aesthetic company and subsidiary of CMS announced that the companies have entered into a Collaboration and License Agreement for the…
Read More...

AbCellera and Rallybio Corporation announced that they have entered into a strategic alliance to discover, develop, and commercialize novel antibody-based therapeutics for rare…
Read More...